U.S. Electrical Stock News

If you are wondering whether Coca-Cola Consolidated is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$195.20, with returns of 17.5% over 7 days, 30.0% over 30 days, 30.3% year to date and 41.2% over 1 year. The 3 year return is 262.7% and the 5 year return is roughly 7x the earlier level. Recent news around Coca-Cola Consolidated has largely focused on its position...

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...

Royalty Pharma’s latest earnings, guidance and buyback update Royalty Pharma (RPRX) drew investor attention after releasing 2026 Portfolio Receipts guidance, reporting fourth quarter and full year 2025 results, and confirming progress on its ongoing share repurchase program. See our latest analysis for Royalty Pharma. Royalty Pharma’s latest guidance and earnings update comes after a period of stronger momentum, with a 30 day share price return of 12.38% and a 1 year total shareholder return...

If you are wondering whether Allison Transmission Holdings is still fairly priced after its strong run, this article will walk through what the current share price might be implying about value. The stock last closed at US$121.99, with returns of 3.9% over 7 days, 11.3% over 30 days, 23.3% year to date and 24.2% over the past year. The 3 year and 5 year returns are very large at about 1.7x and 2.3x respectively. Recent coverage has focused on Allison Transmission Holdings as a long term...

NIO (NYSE:NIO) reports surpassing 100 million cumulative battery swaps across its network. The company sets new single day battery swap records during the 2026 Spring Festival period. NIO initiates a large scale software recall affecting more than 246,000 vehicles due to a screen related issue flagged by Chinese regulators. NIO, the premium electric vehicle maker listed on the NYSE under ticker NIO, has built its brand around Battery as a Service, where drivers can quickly exchange depleted...

AES (NYSE:AES) has agreed to develop and supply energy generation facilities for Google’s new data center in Wilbarger County, Texas. The partnership extends AES’s long-running collaboration with Google to support data center growth with large-scale energy solutions. The agreement is structured as a long-term arrangement that is expected to support local economic activity and new energy infrastructure in the region. For you as an investor, this highlights how AES is positioning itself as an...

A law firm has opened an investigation into McKesson's Board of Directors over potential breaches of fiduciary duty tied to a 2013 stock incentive plan. The review focuses on the Board's recommendation that shareholders approve issuing a substantial number of additional shares and the possible dilutive effect on existing holders. The inquiry centers on whether the Board acted in the best interests of shareholders when it supported the expanded stock issuance. For investors in McKesson,...

Recent performance snapshot With no single headline event setting the tone, Mueller Water Products (MWA) has drawn attention through its recent share performance and financial profile, prompting investors to reassess how this water infrastructure supplier fits into their portfolios. The stock last closed at $29.92, with reported total returns of 1.1% over the past day and a small decline over the past week. Over the past month and past 3 months, returns are in double digits, and the reported...

Why SolarEdge’s latest earnings and guidance caught the market’s attention SolarEdge Technologies (SEDG) recently reported quarterly and full year 2025 results, issued new 2026 revenue guidance of US$290 million to US$320 million for the first quarter, and outlined a fresh partnership with WeaveGrid. See our latest analysis for SolarEdge Technologies. The earnings update, new 2026 revenue guidance and WeaveGrid partnership have arrived alongside a sharp shift in sentiment, with a 30 day share...

Iovance Biotherapeutics (IOVA) closed out FY 2025 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.18, alongside a quarterly net loss of US$71.9 million. The company has seen quarterly revenue move from US$73.7 million in Q4 2024 to US$86.8 million in Q4 2025, while basic EPS shifted from a loss of US$0.26 to a loss of US$0.18 over the same period, setting up a results season where investors are weighing growing sales against ongoing losses. With trailing twelve...

If you are wondering whether Strategy's current share price reflects its true worth, this article will walk through what the numbers say about value and where the market might be out of sync. The stock last closed at US$124.61, with returns of a 0.5% decline over 7 days, a 22.4% decline over 30 days, a 20.7% decline year to date and a 52.7% decline over 1 year, set against a very large gain of around 4x over 3 years and a 70.3% gain over 5 years. Recent price moves sit alongside ongoing...

Rackspace Technology (RXT) has quickly moved onto many investors’ radars after announcing a partnership with Palantir Technologies that positions the company as a managed services provider for Palantir’s data and AI platforms. See our latest analysis for Rackspace Technology. The Palantir announcement has coincided with a sharp shift in sentiment, with a 7 day share price return of 248.45% and a 30 day share price return of 82.07%. However, the 1 year total shareholder return of 43.41% and 5...

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...

What the Hiab dealer agreement could mean for Custom Truck One Source (CTOS) Hiab’s new dealer agreement with Custom Truck One Source (CTOS) expands sales and service coverage for HIAB loader cranes and MOFFETT truck mounted forklifts across multiple US states, giving CTOS broader access to equipment customers. See our latest analysis for Custom Truck One Source. The Hiab deal lands at a time when momentum in Custom Truck One Source’s share price has been building, with a 30 day share price...

If you are wondering whether Cognex at around US$57.88 is priced for perfection or still offers value, this article will walk through what the current share price may be implying. The stock has returned 1.4% over the past week, 45.6% over the last 30 days, 56.7% year to date, 78.0% over 1 year and 24.9% over 3 years, while the 5 year return sits at a 27.9% decline. This gives a mixed picture for anyone thinking about new money going in today. Recent coverage of Cognex has focused on its role...

Intellia Therapeutics (NasdaqGM:NTLA) has announced new collaborations with AvenCell Therapeutics and Kyverna Therapeutics. The partnerships focus on expanding engineered cell therapies for cancer and autoimmune diseases. These agreements mark a shift in how Intellia aims to apply its gene editing platform across multiple therapeutic areas. Intellia Therapeutics, traded as NasdaqGM:NTLA, is a gene editing company focused on developing CRISPR based therapies. By teaming up with AvenCell...

Why VinFast Auto is Back on Investors’ Radar VinFast Auto (VFS) is drawing fresh interest after two recent developments: a partnership with PlusX Electric in the UAE to grow charging access and digital services, and preliminary January deliveries of 16,172 EVs, up 55% year over year. See our latest analysis for VinFast Auto. Even with January’s delivery update and the PlusX Electric partnership in the UAE in focus, VinFast Auto’s short term share price return has been mixed. The stock has...

If you are wondering whether Venture Global's share price is offering value right now, you are not alone. This article is set up to help you frame that question clearly. The stock last closed at US$9.35, with a 6.6% gain over the past 7 days, a 5.4% decline over 30 days, a 32.8% return year to date, and a 33.3% decline over the last year. Recent coverage around Venture Global has focused on its position in the US energy market and ongoing interest in liquefied natural gas projects, which...

Recent industry reports highlight strong past and projected growth in flexible packaging, emphasizing rising demand for lightweight, sustainable solutions across food, pharmaceutical, and e-commerce applications, with Amcor frequently cited as a key innovator in this space. In parallel, the US nutraceutical packaging market is expected to expand from about US$1.54 billion in 2025 to roughly US$2.12 billion by 2033, underlining a growing opportunity for Amcor in higher-value, safety-focused...

Hecla Mining recently reported its past fourth-quarter and full-year 2025 results, highlighting record sales of US$1.42 billion, net income of US$321.71 million, new 2026 production guidance, continued common and preferred dividends, and board changes including the retirement of long-serving director Stephen F. Ralbovsky and the appointment of Jill Satre as Audit Committee Chair. The company also outlined a sharpened focus on silver, including the planned sale of the Casa Berardi gold mine,...

Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive revenue items and operational pressures in its Medicaid business. These results have prompted several analysts to downgrade their ratings, highlighting concerns about Molina’s ability to sustain Medicaid profitability amid declining premium revenue guidance and volatile revenue and expense...

Kimberly-Clark (KMB) is back on many investors’ screens after recent share price moves, with the stock up over the past month and past 3 months while long term returns remain mixed. See our latest analysis for Kimberly-Clark. The recent momentum, including a 1 month share price return of 8.69% and year to date share price return of 9.58%, contrasts with a weaker 1 year total shareholder return decline of 18.15%, which may indicate improving sentiment after a tougher period. If you are...

In February 2026, Ormat Technologies Inc. announced it had entered into a long-term geothermal Power Purchase Agreement with NV Energy to supply up to 150MW of new geothermal capacity supporting Google's Nevada operations, enabled by NV Energy's Clean Transition Tariff and pending approval by the Public Utilities Commission of Nevada. This portfolio-style PPA structure, with staggered project additions from 2028 to 2030 and a term extending 15 years beyond the final project's start, offers...